Nicholas J Vogelzang. Show Affiliations »
Abstract
Entities: Disease
Mesh： See more » Bone Neoplasms/radiotherapyBone Neoplasms/secondaryDose Fractionation, RadiationHumansMalePain Management/methodsProstatic Neoplasms/pathologyProstatic Neoplasms/radiotherapyRadiopharmaceuticals/adverse effectsRadiopharmaceuticals/therapeutic useRadiotherapy/adverse effectsRadiotherapy/economicsRadiotherapy/methodsRadium/adverse effectsRadium/therapeutic useRisk Assessment
Substances： See more » RadiopharmaceuticalsRadium
Year: 2014 PMID： 24839800
Source DB: PubMed Journal: Oncology (Williston Park) ISSN： 0890-9091 Impact factor: 2.990